Influence Du Cisplatine sur l'expression du Check-Point Immunitaire PD-1/PD-L1 Dans Le Cancer Broncho-Pulmonaire Non A Petites Cellules
Texte intégral
Figure
Documents relatifs
Immune checkpoint inhibitors targeting the programmed death receptor ligand 1 (PD-L1)/programmed death receptor 1 (PD-1) pathway alone or in combination have greatly changed
The expression of PD-1 and its ligands, PD-L1 and PD-L2, was assessed by flow cytometry on peripheral blood mononuclear cells (PBMC) and compared to patients who had
Expression levels of selected biomarkers by untreated and IFN- γγγγ treated melanoma cell-lines No untreated melanoma cells expressed PD-L1 (median 0.36% positive cells)
As explained in Section 2, there are three types of operations that commonly ap- pear in procedures used for balancing binary trees after an insertion or deletion: (1) navigation in
En inhibant c-Myc avec un inhibiteur chimique spécifique, nous avons identifié que l’expression relative d’EBI3 est significativement augmentée dans toutes les
Here, we evaluated the impact of cisplatin treatment on PD-L1 expression analyzing the clinicopathological characteristics of patients who received
expressing PD-L1 in the blood of patients with metastatic breast cancer using a non-. invasive liquid
En Figure 36A, nous pouvons voir les colonies cellulaires formées 10 jours après ensemencement des cellules « VIDE » et « PD-L1 », en condition basale (normoxie)
